Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
2024年8月6日 - 8:00PM
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live
biotherapeutics company, today announced that management will host
a conference call and live audio webcast on August 13, 2024 at 8:30
a.m. ET to discuss second quarter 2024 financial results and
provide business updates.
To access the conference call, please dial
800-715-9871 (domestic) or 646-307-1963 (international) and
reference the conference ID number 4877586. To join the live
webcast, please visit the “Investors and News” section of the Seres
website at www.serestherapeutics.com.
A webcast replay will be available on the Seres
website beginning approximately two hours after the event and will
be archived for approximately 21 days.
About Seres Therapeutics Seres
Therapeutics, Inc. (Nasdaq: MCRB) is a clinical-stage biotechnology
company focused on improving patient outcomes in medically
vulnerable populations through the use of oral cultivated live
biotherapeutics. Seres led the successful development and approval
of VOWST™, the first FDA-approved orally administered microbiome
therapeutic. The Company is evaluating SER-155 in a Phase 1b study
in patients receiving allogeneic hematopoietic stem cell
transplantation. SER-155 is designed to prevent gastrointestinal
(GI)-derived infections and resulting bloodstream infections,
enhance epithelial barrier integrity, and induce immune tolerance
responses to reduce the incidence of graft-versus-host-disease
(GvHD). The Company is also advancing additional cultivated oral
microbiome therapeutics for medically vulnerable populations,
including those with chronic liver disease, cancer neutropenia, and
solid organ transplants. For more information, please visit
www.serestherapeutics.com.
Investor and Media Contacts:
IR@serestherapeutics.com
Carlo Tanzi, Ph.D.Kendall Investor
Relationsctanzi@kendallir.com
Seres Therapeutics (NASDAQ:MCRB)
過去 株価チャート
から 8 2024 まで 9 2024
Seres Therapeutics (NASDAQ:MCRB)
過去 株価チャート
から 9 2023 まで 9 2024